Biotage AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 643 million compared to SEK 384 million a year ago. Net income was SEK 131 million compared to SEK 74 million a year ago. Basic earnings per share from continuing operations was SEK 1.64 compared to SEK 1.12 a year ago. Diluted earnings per share from continuing operations was SEK 1.64 compared to SEK 1.11 a year ago.
For the full year, sales was SEK 1,862 million compared to SEK 1,566 million a year ago. Net income was SEK 246 million compared to SEK 268 million a year ago. Basic earnings per share from continuing operations was SEK 3.34 compared to SEK 4.06 a year ago. Diluted earnings per share from continuing operations was SEK 3.33 compared to SEK 4.04 a year ago.